| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +115.6% |
| Cost of Revenue | $1.8M | +66.2% |
| Gross Profit | $2.3M | +210.5% |
| R&D Expense | $15.9M | +61.6% |
| SG&A Expense | $10.6M | +4.2% |
| Operating Income | -$51.1M | +16.2% |
| Income Tax | $0 | — |
| Net Income | -$50.2M | +17.2% |
| EPS (Basic) | -$1.65 | +64.6% |
| EPS (Diluted) | -$1.65 | +64.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.6M | +34.1% |
| Accounts Receivable | $1.1M | -30.1% |
| Inventory | $446K | +8.8% |
| Current Assets | $15.3M | +30.2% |
| Total Assets | $25.8M | -26.6% |
| Current Liabilities | $12.1M | +66.0% |
| Total Liabilities | $57.2M | +20.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.2M | -7.1% |
| Capital Expenditures | $3.2M | +517.2% |
| Investing Cash Flow | -$3.2M | -522.1% |
| Financing Cash Flow | $28.1M | +37.4% |
| Free Cash Flow | -$25.4M | -19.5% |
| -$31.5M |
| -156.3% |